AVIDITY BIOSCIENCES INC's ticker is RNA and the CUSIP is 05370A108. A total of 114 filers reported holding AVIDITY BIOSCIENCES INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,452,673 | -42.1% | 854,651 | +0.6% | 6.70% | -33.5% |
| Q2 2023 | $9,422,630 | -27.8% | 849,651 | 0.0% | 10.08% | -26.8% |
| Q1 2023 | $13,042,143 | -28.8% | 849,651 | +2.9% | 13.77% | -21.6% |
| Q4 2022 | $18,317,246 | +34.3% | 825,473 | -1.2% | 17.56% | +1.9% |
| Q3 2022 | $13,643,000 | +12.4% | 835,473 | 0.0% | 17.24% | +13.4% |
| Q2 2022 | $12,139,000 | -26.2% | 835,473 | -6.1% | 15.20% | +2.2% |
| Q1 2022 | $16,438,000 | -22.3% | 889,957 | +0.0% | 14.87% | -17.1% |
| Q4 2021 | $21,144,000 | -5.4% | 889,537 | -2.0% | 17.94% | -8.8% |
| Q3 2021 | $22,353,000 | -22.5% | 907,567 | -22.2% | 19.68% | +8.5% |
| Q2 2021 | $28,830,000 | -4.6% | 1,166,747 | -15.8% | 18.14% | -1.6% |
| Q1 2021 | $30,226,000 | -24.6% | 1,385,864 | -11.8% | 18.44% | -8.3% |
| Q4 2020 | $40,096,000 | – | 1,571,160 | – | 20.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALETHEA CAPITAL MANAGEMENT, LLC | 1,571,160 | $40,096,000 | 20.10% |
| Aaron Wealth Advisors LLC | 524,239 | $13,378,000 | 4.90% |
| Octagon Capital Advisors LP | 430,041 | $10,975,000 | 3.80% |
| EcoR1 Capital, LLC | 2,103,950 | $53,693,000 | 2.89% |
| RTW INVESTMENTS, LP | 3,995,000 | $101,952,000 | 1.71% |
| ACUTA CAPITAL PARTNERS, LLC | 246,200 | $6,283,000 | 1.71% |
| Cormorant Asset Management, LP | 2,464,547 | $62,895,000 | 1.50% |
| Logos Global Management LP | 671,454 | $17,136,000 | 1.47% |
| Boxer Capital, LLC | 1,121,327 | $28,616,000 | 0.92% |
| HighVista Strategies LLC | 26,665 | $680,000 | 0.43% |